David Hyman

E561042

David Hyman is an oncologist and biopharmaceutical executive known for his leadership in precision cancer medicine and his role in building innovative oncology drug development programs.

All labels observed (1)

Label Occurrences
David Hyman canonical 1

How this entity was disambiguated

Statements (26)

Predicate Object
instanceOf biopharmaceutical executive ⓘ
oncologist ⓘ
person ⓘ
contributedTo advancement of precision oncology drug development ⓘ
design of innovative oncology clinical trials ⓘ
fieldOfWork cancer drug development ⓘ
clinical trials ⓘ
oncology ⓘ
precision oncology ⓘ
focusesOn developing targeted therapies for cancer ⓘ
innovative oncology drug development ⓘ
precision medicine strategies in oncology ⓘ
hasExpertise early-phase oncology clinical trials ⓘ
molecularly targeted agents ⓘ
oncology translational research ⓘ
precision medicine clinical development ⓘ
targeted cancer therapies ⓘ
knownFor building innovative oncology drug development programs ⓘ
leadership in precision cancer medicine ⓘ
notableRole leader in precision cancer medicine ⓘ
occupation biotech executive ⓘ
medical oncologist ⓘ
specialty medical oncology ⓘ
precision cancer medicine ⓘ
worksOn cancer clinical development programs ⓘ
precision oncology trials ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Loxo Oncology (acquired) → coFounder → David Hyman ⓘ
subject surface form: Loxo Oncology